Literature DB >> 9678892

Case report: DNA fragmentation in glial cells in a cerebral biopsy from a multiple sclerosis patient.

N Benjelloun1, A Ménard, C Charriaut-Marlangue, K Mokhtari, H Perron, J J Hauw, F Rieger.   

Abstract

Multiple sclerosis is characterized by myelin destruction and oligodendrocyte loss. The neuropathological hallmark of the disease is the presence of demyelinated plaques in the central nervous system. We have recently found a gliotoxic factor in MS cerebrospinal fluid which induces programmed cell death in vitro, in glial cells. Here we show DNA fragmentation and glial cell death in biopsy samples, obtained from a patient who underwent surgery with suspicion of tumor, and whose disease record, including brain autopsy, demonstrated an active multiple sclerosis. We used the in situ TUNEL technique, a method which sensitively detects the DNA fragmentation accompanying programmed cell death in tissue sections, and compatible with classical fixation techniques. We found intense DNA fragmentation in nuclei of glial cells at-or very near-to the site of demyelination. A double labeling technique showed that glial fibrillary associated protein positive astrocytes may undergo programmed cell death in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678892

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  2 in total

1.  Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120.

Authors:  Yanjing Yang; Honghong Yao; Yaman Lu; Chao Wang; Shilpa Buch
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

2.  Inhibition of myelin-cleaving poteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II.

Authors:  Tiziana Latronico; Maria Teresa Branà; Pasqua Gramegna; Anna Fasano; Gaetano Di Bari; Grazia Maria Liuzzi
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.